Search

Your search keyword '"Vitale, Carmine"' showing total 639 results
Start Over Author "Vitale, Carmine"
639 results on '"Vitale, Carmine"'

2. Correction: Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients

Author

Aiello, Edoardo Nicolò, D’Iorio, Alfonsina, Solca, Federica, Torre, Silvia, Bonetti, Ruggero, Scheveger, Francesco, Colombo, Eleonora, Maranzano, Alessio, Maderna, Luca, Morelli, Claudia, Doretti, Alberto, Amboni, Marianna, Vitale, Carmine, Verde, Federico, Ferrucci, Roberta, Barbieri, Sergio, Zirone, Eleonora, Priori, Alberto, Pravettoni, Gabriella, Santangelo, Gabriella, Silani, Vincenzo, Ticozzi, Nicola, Ciammola, Andrea, and Poletti, Barbara

Published
2024
Full Text
View/download PDF

7. Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients

Author

Aiello, Edoardo Nicolò, D’Iorio, Alfonsina, Solca, Federica, Torre, Silvia, Bonetti, Ruggero, Scheveger, Francesco, Colombo, Eleonora, Maranzano, Alessio, Maderna, Luca, Morelli, Claudia, Doretti, Alberto, Amboni, Marianna, Vitale, Carmine, Verde, Federico, Ferrucci, Roberta, Barbieri, Sergio, Zirone, Eleonora, Priori, Alberto, Pravettoni, Gabriella, Santangelo, Gabriella, Silani, Vincenzo, Ticozzi, Nicola, Ciammola, Andrea, and Poletti, Barbara

Published
2023
Full Text
View/download PDF

10. Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson's disease

Author

Conferencia de Rectores de las Universidades Españolas, Consejo Superior de Investigaciones Científicas (España), Maggi, Gianpaolo [0000-0003-3155-739X], Loayza, Francis [0000-0002-6283-3679], Vitale, Carmine [0000-0003-3015-1929], Santangelo, Gabriella [0000-0002-7728-852X], Obeso, Ignacio [0000-0001-8783-7281], Maggi, Gianpaolo, Loayza, Francis, Vitale, Carmine, Santangelo, Gabriella, Obeso, Ignacio, Conferencia de Rectores de las Universidades Españolas, Consejo Superior de Investigaciones Científicas (España), Maggi, Gianpaolo [0000-0003-3155-739X], Loayza, Francis [0000-0002-6283-3679], Vitale, Carmine [0000-0003-3015-1929], Santangelo, Gabriella [0000-0002-7728-852X], Obeso, Ignacio [0000-0001-8783-7281], Maggi, Gianpaolo, Loayza, Francis, Vitale, Carmine, Santangelo, Gabriella, and Obeso, Ignacio

Abstract

Although apathy and impulse control disorders (ICDs) are considered to represent opposite extremes of a continuum of motivated behavior (i.e., hypo- and hyperdopaminergic behaviors), they may also co-occur in Parkinson's disease (PD).

Published
2024

15. Theory of mind in mild cognitive impairment and Parkinson's disease: The role of memory impairment

Author

Università degli studi della Campania Luigi Vanvitelli, Ministero della Salute, Maggi, Gianpaolo, Giacobbe, Chiara, Vitale, Carmine, Amboni, Marianna, Obeso, Ignacio, Santangelo, Gabriella, Università degli studi della Campania Luigi Vanvitelli, Ministero della Salute, Maggi, Gianpaolo, Giacobbe, Chiara, Vitale, Carmine, Amboni, Marianna, Obeso, Ignacio, and Santangelo, Gabriella

Abstract

[Background] Social cognition is impaired in Parkinson’s disease (PD). Whether social cognitive impairment (iSC) is a by-product of the underlying cognitive deficits in PD or a process independent of cognitive status is unknown. To this end, the present study was designed to investigate the weight of specific cognitive deficits in social cognition, considering different mild cognitive impairment subtypes of PD (PD-MCI)., [Methods] Fifty-eight PD patients underwent a neuropsychological battery assessing executive functions, memory, language, and visuospatial domains, together with social cognitive tests focused on theory of mind (ToM). Patients were divided into subgroups according to their clinical cognitive status: amnestic PD-MCI (PD-aMCI, n = 18), non-amnestic PD-MCI (PD-naMCI, n = 16), and cognitively unimpaired (PD-CU, n = 24). Composite scores for cognitive and social domains were computed to perform mediation analyses., [Results] Memory and language impairments mediated the effect of executive functioning in social cognitive deficits in PD patients. Dividing by MCI subgroups, iSC occurred more frequently in PD-aMCI (77.8%) than in PD-naMCI (18.8%) and PD-CU (8.3%). Moreover, PD-aMCI performed worse than PD-CU in all social cognitive measures, whereas PD-naMCI performed worse than PD-CU in only one subtype of the affective and cognitive ToM tests., [Conclusions] Our findings suggest that ToM impairment in PD can be explained by memory dysfunction that mediates executive control. ToM downsides in the amnesic forms of PD-MCI may suggest that subtle changes in social cognition could partly explain future transitions into dementia. Hence, the evaluation of social cognition in PD is critical to characterize a possible behavioral marker of cognitive decline.

Published
2024

16. Effects of Biodanza ® SRT on Motor, Cognitive, and Behavioral Symptoms in Patients with Parkinson's Disease: A Randomized Controlled Study.

Author

Vitale, Carmine, Rosa, Roberta, Agosti, Valeria, Siciliano, Mattia, Barra, Giuseppe, Maggi, Gianpaolo, and Santangelo, Gabriella

Subjects
*APATHY, *PARKINSON'S disease, *VERBAL memory, *SYMPTOMS, *SHORT-term memory
Abstract

Rolando Toro's Biodanza (SRT) is a therapeutic strategy that uses movement, music, and emotions to induce integrative living experiences. The present study aims to explore the efficacy of a three-month SRT intervention on motor, cognitive, and behavioral symptoms in patients with Parkinson's disease (PD). This study employed a randomized between-group design. Twenty-eight non-demented PD patients were enrolled in this study. Out of these, fourteen patients were assigned to the active treatment group using the Biodanza SRT system and fourteen to the untreated control group. The study group attended 2 h SRT classes once a week, completing twelve lessons in twelve weeks. All patients underwent: (i) a neurological examination to measure the severity of motor symptoms, balance, mobility, and risk of falls, and (ii) a neuropsychological battery to assess cognitive status, apathy, depressive symptomatology, and perceived quality of life (QoL), at study entry (T0) and at twelve weeks (T1, end of dance training). At T1, we observed a significant improvement in motor (i.e., severity of motor symptoms and balance) and cognitive parameters (i.e., working memory and delayed verbal memory) in all treated patients compared with the controls. Furthermore, a significant improvement in the social support dimension was found in all treated patients compared to the controls. A trend toward increased apathy was found in untreated patients at T1. The three-month Biodanza intervention significantly ameliorated the motor parameters of PD patients, with a parallel improvement in cognitive and QoL status. Hence, Biodanza intervention can, in the short term, represent a useful personalized medical intervention for the management of Parkinson's disease. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Correction: Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients

Author

Aiello, Edoardo Nicolò, primary, D’Iorio, Alfonsina, additional, Solca, Federica, additional, Torre, Silvia, additional, Bonetti, Ruggero, additional, Scheveger, Francesco, additional, Colombo, Eleonora, additional, Maranzano, Alessio, additional, Maderna, Luca, additional, Morelli, Claudia, additional, Doretti, Alberto, additional, Amboni, Marianna, additional, Vitale, Carmine, additional, Verde, Federico, additional, Ferrucci, Roberta, additional, Barbieri, Sergio, additional, Zirone, Eleonora, additional, Priori, Alberto, additional, Pravettoni, Gabriella, additional, Santangelo, Gabriella, additional, Silani, Vincenzo, additional, Ticozzi, Nicola, additional, Ciammola, Andrea, additional, and Poletti, Barbara, additional

Published
2023
Full Text
View/download PDF

33. Prevalence and clinical aspects of obstructive sleep apnea in Parkinson disease: A meta‐analysis.

Author

Maggi, Gianpaolo, Giacobbe, Chiara, Iannotta, Federica, Santangelo, Gabriella, and Vitale, Carmine

Subjects
SLEEP apnea syndromes, PARKINSON'S disease, RAPID eye movement sleep, MOVEMENT disorders, HYPERSOMNIA, SLEEP disorders, BODY mass index
Abstract

Background and Purpose: Obstructive sleep apnea (OSA) frequently occurs in Parkinson Disease (PD), probably caused by upper airway dysfunctions or shared pathogenetic mechanisms. OSA may precede PD diagnosis or worsen throughout its course, but its relationship with clinical features and dopaminergic medication remains unclear. This meta‐analysis aimed to provide a reliable estimate of OSA prevalence in the PD population (PD‐OSA) and to clarify its clinical associated factors to help clinicians in understanding the underlying pathophysiological mechanisms. Methods: A systematic literature search was performed up to April 2023 using the PubMed, Scopus, and PsycINFO databases. Articles were included if they provided data on PD patients with and without OSA. Pooled prevalence for PD‐OSA was calculated using the proportions of PD participants diagnosed with OSA. Demographic and clinical features associated with PD‐OSA were explored by comparing PD patients with and without OSA. Results: Seventeen studies were included in the meta‐analysis. Pooled OSA prevalence was 45% of a total sample of 1448 PD patients and was associated with older age, male sex, higher body mass index (BMI), more severe motor disturbances and periodic limb movements, reduced risk of rapid eye movement sleep behavior disorder, intake of dopamine agonists, and worse excessive daytime sleepiness. No relationship emerged with cognitive functioning and neuropsychiatric manifestations. Conclusions: OSA affects nearly half of PD patients as a secondary outcome of predisposing factors such as older age and higher BMI in addition to PD‐related motor impairment. Future studies should focus on determining the impact of both clinical features and dopaminergic medication on the development of PD‐OSA. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.

Author

D'Iorio, Alfonsina, Aiello, Edoardo Nicolò, Amboni, Marianna, Vitale, Carmine, Verde, Federico, Silani, Vincenzo, Ticozzi, Nicola, Ciammola, Andrea, Poletti, Barbara, and Santangelo, Gabriella

Abstract

Background: This study aimed at: (1) assessing, in an Italian cohort of non-demented Parkinson's disease (PD) patients, the construct validity of the Montreal Cognitive Assessment (MoCA) against both first- and second-level cognitive measures; (2) delivering an exhaustive and updated evaluation of its diagnostic properties. Methods: A retrospective cohort of N = 237 non-demented PD patients having been administered the MoCA was addressed, of whom N = 169 further underwent the Mini-Mental State Examination (MMSE) and N = 68 the Parkinson's Disease Cognitive Rating Scale (PD-CRS). A subsample (N = 60) also underwent a second-level cognitive battery encompassing measures of attention/executive functioning, language, memory, praxis and visuo-spatial abilities. Construct validity was assessed against both the PD-CRS and the second-level cognitive battery. Diagnostics were tested via receiver-operating characteristics analyses against a below-cut-off MMSE score. Results: The MoCA was associated with both PD-CRS scores (p <.001) and the vast majority of second-level cognitive measures (ps <.003). Both raw and adjusted MoCA scores proved to be highly accurate to the aim of identifying patients with MMSE-confirmed cognitive dysfunctions. A MoCA score adjusted for age and education according to the most recent normative dataset and < 19.015 is herewith suggested as indexing cognitive impairment in this population (AUC =.92; sensitivity =.92; specificity =.80). Discussion: The Italian MoCA is a valid and diagnostically sound screener for global cognitive inefficiency in non-demented PD patients. Further studies are nevertheless needed that confirm its diagnostic values against a measure other than the MMSE. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results